A Minnesota-based startup company called MNPHARM plans to use tobacco plants to produce personalized treatments for patients battling cancer. Founded by Jeff Reinert and Dave Roeser, MNPHARM uses a process that combines technological advances in Read More
Tags :Jeff Reinert
Recent Posts
- U.S. Market Poised for Disruption
- New KT&G CEO Engages Employees
- Sullivan and Mish Resign From 22nd Century Board
- Philip Morris Pakistan Urges Action Against Illicit Trade
- Philippines: Momentum Building for Disposables Ban
- Healthcare Providers Urged to Discuss Vapes
- Vape Shops Challenge Kentucky Registry Bill
- Smokers Ordered to Keep Their Distance
- Former BAT Company Does Ruble-Yuan Swaps
- Cuban Origin Ruling Final: Court
- Mustafa Named Influential Executive
- CTP Launches Webpage on Relative Risks
- PCA Reflects on Successful Trade Show
- Britain’s Generation Ban Passes First Vote
- PMI Eyes Philippines Leaf for Smoke-Free